Telomerase reactivation is a prerequisite step for most tumor immortalization, but 10–15% of tumor types acquire alternative pathways to maintain their telomere length for proliferation, collectively known as Alternative Lengthening of Telomeres (ALT) (Bryan et al. 1997; Pickett and Reddel 2015). This evidence concerns the gene GPT and neoplasm.